Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VX-710 in Combination With Doxorubicin and Vincristine for Recurrent Small Cell Lung Cancer
NCT00003847Phase 2Terminated
- Sponsor
- Vertex Pharmaceuticals
- Start
- Dec 1998
- Primary completion
- Feb 2001
- Countries
- 1
01
Overview
A Phase 2 trial of biricodar in small cell lung cancer (SCLC), sponsored by Vertex Pharmaceuticals. Started Dec 1998; status: terminated.
02
Drugs
biricodar
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00003847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003847.